Ksenia Medvedeva, A. Baulin, O. Lepilina, K. M. Kvashnin, S. Ilyalov
{"title":"两阶段伽玛刀放射治疗脑转移","authors":"Ksenia Medvedeva, A. Baulin, O. Lepilina, K. M. Kvashnin, S. Ilyalov","doi":"10.21870/0131-3878-2022-31-1-136-149","DOIUrl":null,"url":null,"abstract":"The aim of this study was to assess the efficacy and safety of two-stage stereotactic radiosurgery using Gamma Knife for treatment of brain metastases. Staging was applied to patients with large metastases, as well as to metastases located near critical structures. In a group of 31 patients, treatment was carried out in 2 stages with 2-4 weeks interval. The mean tumor volume at the time of the first radiosurgery was 10.4 cm3 (0.52 to 19.07; 95% CI: 8.2-12 cm3). The marginal dose at the first and second stages of radiosurgery ranged from 12 to 14.4 Gy, respectively. Median fol-low-up time was 169 days. Overall survival rate, local control, the incidence of complications, as well as changes in functional status were evaluated. Decrease in volume of tumors between irra-diation sessions averaged 36.2%. Overall survival at 3, 6, 12 months was 70, 57.7 and 52%, re-spectively. Local control after 3, 6, 12 months was 92, 87 and 66%, respectively. Radionecrosis was found out in 2 patients. Increase of Carnovsky index in study group after treatment was by an average of 10 points (p=0.007). Thus, two-stage trained stereotactic radiosurgery can be a safe and effective alternative to surgical treatment of brain metastases without worsening the neuro-logical status of patients.","PeriodicalId":6315,"journal":{"name":"\"Radiation and Risk\" Bulletin of the National Radiation and Epidemiological Registry","volume":"63 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Two-stage Gamma Knife radiosurgery for brain metastases\",\"authors\":\"Ksenia Medvedeva, A. Baulin, O. Lepilina, K. M. Kvashnin, S. Ilyalov\",\"doi\":\"10.21870/0131-3878-2022-31-1-136-149\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The aim of this study was to assess the efficacy and safety of two-stage stereotactic radiosurgery using Gamma Knife for treatment of brain metastases. Staging was applied to patients with large metastases, as well as to metastases located near critical structures. In a group of 31 patients, treatment was carried out in 2 stages with 2-4 weeks interval. The mean tumor volume at the time of the first radiosurgery was 10.4 cm3 (0.52 to 19.07; 95% CI: 8.2-12 cm3). The marginal dose at the first and second stages of radiosurgery ranged from 12 to 14.4 Gy, respectively. Median fol-low-up time was 169 days. Overall survival rate, local control, the incidence of complications, as well as changes in functional status were evaluated. Decrease in volume of tumors between irra-diation sessions averaged 36.2%. Overall survival at 3, 6, 12 months was 70, 57.7 and 52%, re-spectively. Local control after 3, 6, 12 months was 92, 87 and 66%, respectively. Radionecrosis was found out in 2 patients. Increase of Carnovsky index in study group after treatment was by an average of 10 points (p=0.007). Thus, two-stage trained stereotactic radiosurgery can be a safe and effective alternative to surgical treatment of brain metastases without worsening the neuro-logical status of patients.\",\"PeriodicalId\":6315,\"journal\":{\"name\":\"\\\"Radiation and Risk\\\" Bulletin of the National Radiation and Epidemiological Registry\",\"volume\":\"63 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"\\\"Radiation and Risk\\\" Bulletin of the National Radiation and Epidemiological Registry\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.21870/0131-3878-2022-31-1-136-149\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"\"Radiation and Risk\" Bulletin of the National Radiation and Epidemiological Registry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21870/0131-3878-2022-31-1-136-149","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Two-stage Gamma Knife radiosurgery for brain metastases
The aim of this study was to assess the efficacy and safety of two-stage stereotactic radiosurgery using Gamma Knife for treatment of brain metastases. Staging was applied to patients with large metastases, as well as to metastases located near critical structures. In a group of 31 patients, treatment was carried out in 2 stages with 2-4 weeks interval. The mean tumor volume at the time of the first radiosurgery was 10.4 cm3 (0.52 to 19.07; 95% CI: 8.2-12 cm3). The marginal dose at the first and second stages of radiosurgery ranged from 12 to 14.4 Gy, respectively. Median fol-low-up time was 169 days. Overall survival rate, local control, the incidence of complications, as well as changes in functional status were evaluated. Decrease in volume of tumors between irra-diation sessions averaged 36.2%. Overall survival at 3, 6, 12 months was 70, 57.7 and 52%, re-spectively. Local control after 3, 6, 12 months was 92, 87 and 66%, respectively. Radionecrosis was found out in 2 patients. Increase of Carnovsky index in study group after treatment was by an average of 10 points (p=0.007). Thus, two-stage trained stereotactic radiosurgery can be a safe and effective alternative to surgical treatment of brain metastases without worsening the neuro-logical status of patients.